Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/1998
10/07/1998EP0868425A1 Phospholipid derivatives of phosphono-carboxylic acids, the production of said derivatives and the use of said derivatives as antiviral medicaments
10/07/1998EP0868420A1 3-pyrazolecarboxamide derivatives having cannabinoid receptor affinity
10/07/1998EP0868198A1 FC$g(e)-PE CHIMERIC PROTEIN FOR TARGETED TREATMENT OF ALLERGY RESPONSES, A METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
10/07/1998EP0868182A1 Process for production of piperidine derivatives
10/07/1998EP0868178A1 Antagonists of gonadotropin releasing hormone
10/07/1998EP0765165A4 Constrained peptides
10/07/1998EP0720598B1 Phenoxyphenyl cyclopentenyl hydroxyureas
10/07/1998EP0708771B1 Benzyloxyquinuclidines as substance p antagonists
10/07/1998CN1195294A Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligang antibodies, as therapeutic agents for treatment of immunological disease
10/07/1998CN1195289A Pharmaceutical compositions
10/07/1998CN1040126C Process for preparing protein
10/07/1998CN1040108C Process for preparing compound of benzyl indoles
10/06/1998US5817771 Cell-targeted lytic pore-forming agents
10/06/1998US5817749 Cyclic pentapeptides
10/06/1998US5817661 Trans cyclopentanyl purine analogs useful as immunosuppressants
10/06/1998US5817659 Stable crystalline tetrahydrofolic acid salts
10/06/1998US5817648 Vitamin D3 analogues having an unsaturated side chain
10/06/1998US5817643 Immunostimulants
10/06/1998US5817511 Nucleotide sequence coding for variable regions of the α chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
10/06/1998US5817494 Anticancer agents; viricides
10/06/1998US5817311 Graft verses host disease, transplant rejection
10/06/1998US5817308 Tolerogenic fusion proteins of immunoglobulins and methods for inducing and maintaining tolerance
10/06/1998CA2167715C Heteroaryl cycloalkenyl hydroxyureas
10/02/1998CA2233787A1 Sialoadhesin family member-3
10/02/1998CA2233785A1 Tumor necrosis related receptor, tr7
10/02/1998CA2232743A1 A tnf homologue, tl5
10/02/1998CA2226910A1 Sialoadhesin family member-2 (saf-2)
10/01/1998WO1998042855A1 Rapid production of autologous tumor vaccines by using hsv amplicon vectors
10/01/1998WO1998042850A1 Anticoagulant fusion protein anchored to cell membrane
10/01/1998WO1998042834A1 Bi- or multifunctional molecules based on a dendroaspin scaffold
10/01/1998WO1998042752A1 Immunotherapeutic ctla-4 binding peptides
10/01/1998WO1998042750A1 ANTIGENIC FUSIONPROTEIN CARRYING GALα1,3GAL EPITOPES
10/01/1998WO1998042739A2 Secreted proteins and polynucleotides encoding them
10/01/1998WO1998042738A1 87 human secreted proteins
10/01/1998WO1998042737A2 Peptides for the treatment of systemic lupus erythematosus
10/01/1998WO1998042734A1 Process of purification of cyclosporin
10/01/1998WO1998042721A1 Uronium salt conjugate vaccines
10/01/1998WO1998042708A2 Pharmaceutically active tricyclic amines
10/01/1998WO1998042706A1 Method of making arylamino triazolopyridines
10/01/1998WO1998042670A1 Novel pyridine derivatives and pharmaceutical compositions containing them
10/01/1998WO1998042659A2 Aryl- or heteroarylsulfonamide substituted hydroxamic acid derivates, process for their preparation and their use as pharmaceuticals
10/01/1998WO1998042379A2 Chemically and thermally stable norastemizole formulations
10/01/1998WO1998042377A1 Preventives or remedies for sensitized t cell-related diseases containing il-6 antagonists as the active ingredient
10/01/1998WO1998042366A1 The use of proteins extractable from animal organs for the preparation of medicaments for the treatment of pathological conditions characterized by hyperproduction of tumor necrosis factor (tnf)
10/01/1998WO1998042354A1 Chemokines that inhibit immunodeficiency virus infection and methods based thereon
10/01/1998WO1998042353A1 Modulation of human mast cell activation
10/01/1998WO1998042349A1 Mixtures of at least two reverse transcriptase inhibitors and hydroxycarbamide, in particular for inhibiting retroviral spread
10/01/1998WO1998042344A1 Pharmaceutical composition
10/01/1998WO1998042338A1 Extension of the expression of transgenic proteins by immunomodulation
10/01/1998WO1998042321A2 Liquid compositions comprising lamivudine
10/01/1998WO1998024427A3 Compositions and methods for treating or preventing inflammatory diseases
10/01/1998WO1998022580A3 Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation
10/01/1998DE19713001A1 Graminaenpollenallergenmutanten zur spezifischen Immuntherapie, deren Herstellung und Verwendung Graminaenpollenallergenmutanten for specific immunotherapy, their preparation and use
10/01/1998CA2287156A1 Rapid production of autologous tumor vaccines by using hsv amplicon vectors
10/01/1998CA2285702A1 Anticoagulant fusion protein anchored to cell membrane
10/01/1998CA2285439A1 Aryl- or heteroarylsulfonamide substituted hydroxamic acid derivates, process for their preparation and their use as pharmaceuticals
10/01/1998CA2284705A1 Chemically and thermally stable norastemizole formulations
10/01/1998CA2284633A1 Chemokines that inhibit immunodeficiency virus infection and methods based thereon
10/01/1998CA2284550A1 87 human secreted proteins
10/01/1998CA2284548A1 The use of proteins extractable from animal organs for the preparation of medicaments for the treatment of pathological conditions characterized by hyperproduction of tumor necrosis factor (tnf)
10/01/1998CA2284483A1 Mixtures of at least two reverse transcriptase inhibitors and hydroxycarbamide, in particular for inhibiting retroviral spread
10/01/1998CA2284200A1 Novel pyridine derivatives and pharmaceutical compositions containing them
10/01/1998CA2284095A1 Bi- or multifunctional molecules based on a dendroaspin scaffold
10/01/1998CA2283792A1 Peptides for the treatment of systemic lupus erythematosus
10/01/1998CA2283762A1 Uronium salt conjugate vaccines
10/01/1998CA2283631A1 Secreted proteins and polynucleotides encoding them
10/01/1998CA2283230A1 Method of making arylamino triazolopyridines
10/01/1998CA2275389A1 Pharmaceutically active tricyclic amines
10/01/1998CA2255765A1 Antigenic fusionprotein carrying gal.alpha.1,3gal epitopes
10/01/1998CA2233783A1 Anti-fas antibodies
09/1998
09/30/1998EP0867513A2 Interleukin-1 beta converting enzyme apoptosis protease-10
09/30/1998EP0867509A2 Tumor necrosis related receptor, TR5
09/30/1998EP0867508A2 Olfactory receptor of the 7-transmembrane receptor family - OLRCC15 receptor
09/30/1998EP0867507A1 LicB polypeptides from Streptococcus pneumoniae
09/30/1998EP0867451A2 Monoclonal antibodies reactive with defined regions of the T cell antigen receptor
09/30/1998EP0867438A1 Rapamycin derivatives and their use, particularly as immunosuppressants
09/30/1998EP0867189A2 Monoclonal antibodies reactive with defined regions of the T cell antigen receptor
09/30/1998EP0866871A1 Compositions and method for stimulating antibody release by b lymphocytes
09/30/1998EP0866865A1 Chimeric oligomers having an rna-cleavage activity
09/30/1998EP0866801A1 Cyclopeptolides
09/30/1998EP0866726A1 Pulmonary administration of dry powder alpha 1-antitrypsin
09/30/1998EP0866716A1 Methods of treating disorders of non-visual sensory epithelia
09/30/1998EP0866701A1 Synergistic immunosuppressant composition containing a 2,2'-bi-1h-pyrrole compound
09/30/1998EP0866691A1 Sublingual and buccal administration of selegiline
09/30/1998EP0866656A1 Inhibition of tumor necrosis factor alpha
09/30/1998EP0866655A2 Murine model for human carcinoma
09/30/1998EP0643769B1 RECOMBINANT TIMOTHY GRASS POLLEN ALLERGEN $i(Phl p) II
09/30/1998CN1194143A Sea horse oral liquor and its preparing method
09/30/1998CN1039998C Substituted cycloalkylacetamides and its preparation, medicine and use
09/30/1998CA2232471A1 Antihistaminic substance of stevia origin
09/29/1998US5814648 N-hydroxyureas as antiinflammatory agents
09/29/1998US5814627 3, 5-disubstituted and 3, 4, 5-trisubstituted 2-isoxazolines and isoxazoles, process for their preparation and their use as pharmaceuticals
09/29/1998US5814484 Yeast cell comprising specified dna molecule producing biologically active polypeptide
09/29/1998US5814480 Polynucleotide sequence, for detection of the polypeptide in a biological sample
09/29/1998CA2100503C Piperidine derivatives of benzimidazole
09/29/1998CA2020474C Antiinflammatory and/or antiallergic composition
09/27/1998CA2231055A1 Interleukin-1 beta converting enzyme like apoptosis protease-10
09/24/1998WO1998041629A2 Death domain containing receptor 5
09/24/1998WO1998041539A2 Secreted proteins and polynucleotides encoding them
09/24/1998WO1998041526A1 Novel pyrimidine derivative
1 ... 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 ... 1172